Dachaigh › Aillse Prostata › Wisconsin › Madison
Sgrùdaidhean clionaigeach Aillse Prostata ann an Madison, WI
Tha 29 sgrùdaidhean airson Aillse Prostata a’ lorg phàirtichean aig làraichean ann agus timcheall air Madison (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
A’ fastadhÌre 1/2
- University of Wisconsin Carbone Cancer Center, Madison
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
A’ fastadhÌre 3
- William S Middleton VA Medical Center, Madison
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- William S Middleton VA Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
PET/CT Characterization of Treatment Resistance
A’ fastadh
- University of Wisconsin, Madison
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
A’ fastadhÌre 3
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
A’ fastadhÌre 2
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
A’ fastadhÌre 2
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
A’ fastadhÌre 3
- University Hospital and UW Health Clinics ( Site 0065), Madison
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
A’ fastadhÌre 2
- Carbone Cancer Center University of Wisconsin-Madison, Madison
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
A’ fastadhÌre 3
- University of Wisconsin, Madison
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
A’ fastadhÌre 3
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
A’ fastadhÌre 2
- UW Health Carbone Cancer Center, Madison
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
A’ fastadhSgrùdadh amharc
- University of Wisconsin Carbone Cancer Center, Madison
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
A’ fastadhÌre 2
- University of Wisconsin Carbone Cancer Center-Madison, Madison
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
A’ fastadhÌre 3
- William S Middleton VA Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
FOG-001 in Locally Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- University of Wisconsin, Carbone Cancer Center, Madison
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
A’ fastadhÌre 1
- University of Wisconsin Carbone Cancer Center, Madison
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
A’ fastadhSgrùdadh amharc
- University of Wisconsin-Madison, Madison
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
A’ fastadhÌre 2
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
A’ fastadhÌre 3
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
A’ fastadhÌre 1
- University of Wisconsin Carbone Cancer Center, Madison
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
A’ fastadhÌre 1
- University of Wisconsin, Madison
Using FAPI PET/MRI to Evaluate Prostate Cancer
A’ fastadhÌre 2
- University of Wisconsin, Madison
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
A’ fastadhSgrùdadh amharc
- University of Wisconsin Carbone Cancer Center, Madison
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
A’ fastadhÌre 2/3
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer
A’ fastadhÌre 1
- University of Wisconsin Carbone Cancer Center (UWCCC) - Cancer Connect, Madison
Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC
A’ fastadhÌre 1
- University of Wisconsin - Madison, Madison
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
A’ fastadhÌre 4
- University of Wisconsin, Madison
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
A’ fastadhSgrùdadh amharc
- University of Wisconsin-Madison, Madison
Sgrùdaidhean Aillse Prostata ann am bailtean eile
- New York City, NY103 sgrùdaidhean
- Houston, TX76 sgrùdaidhean
- Los Angeles, CA61 sgrùdaidhean
- Boston, MA59 sgrùdaidhean
- St. Louis, MO46 sgrùdaidhean
- Chicago, IL45 sgrùdaidhean
- San Francisco, CA45 sgrùdaidhean
- Philadelphia, PA44 sgrùdaidhean
- Baltimore, MD43 sgrùdaidhean
- Nashville, TN43 sgrùdaidhean
- Seattle, WA42 sgrùdaidhean
- Washington, DC38 sgrùdaidhean
Sgrùdaidhean eile ann an Madison
- Aillse colorectal23 sgrùdaidhean
- Aillse a' bhroilleach22 sgrùdaidhean
- Ailse metastatach21 sgrùdaidhean
- Leukemia myeloid geur16 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag16 sgrùdaidhean
- Melanoma15 sgrùdaidhean
- Aillse (gach seòrsa)14 sgrùdaidhean
- Cancer Ovarian13 sgrùdaidhean
- Aillse a' Bhroinn11 sgrùdadh
- Cancer Pancreatic10 sgrùdaidhean
- Ailseachadh nan Sgamhan10 sgrùdaidhean
- Myeloma iomaill9 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.